X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1155) 1155
Publication (76) 76
Newsletter (30) 30
Book Review (17) 17
Magazine Article (11) 11
Conference Proceeding (3) 3
Newspaper Article (3) 3
Dissertation (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
risedronate sodium (923) 923
etidronic acid - analogs & derivatives (913) 913
humans (893) 893
female (736) 736
etidronic acid - therapeutic use (572) 572
osteoporosis (541) 541
risedronate (527) 527
aged (480) 480
index medicus (467) 467
middle aged (437) 437
bone density conservation agents - therapeutic use (389) 389
male (326) 326
bisphosphonates (316) 316
bone density - drug effects (297) 297
osteoporosis, postmenopausal - drug therapy (295) 295
endocrinology & metabolism (287) 287
alendronate (282) 282
osteoporosis - drug therapy (281) 281
etidronic acid - administration & dosage (271) 271
alendronate - therapeutic use (229) 229
postmenopausal osteoporosis (225) 225
bone density conservation agents - administration & dosage (222) 222
etidronic acid - pharmacology (216) 216
diphosphonates - therapeutic use (212) 212
animals (211) 211
orthopedics (192) 192
aged, 80 and over (187) 187
women (185) 185
postmenopausal women (184) 184
fractures (183) 183
treatment outcome (181) 181
etidronic acid - adverse effects (168) 168
drug therapy (162) 162
bone density (156) 156
medicine & public health (153) 153
bone density conservation agents - adverse effects (150) 150
risk factors (150) 150
bisphosphonate (136) 136
adult (132) 132
rheumatology (132) 132
bone-mineral density (129) 129
vertebral fractures (127) 127
therapy (126) 126
bone density conservation agents - pharmacology (125) 125
diphosphonates - administration & dosage (120) 120
double-blind method (120) 120
risk (120) 120
bones (119) 119
alendronate - administration & dosage (116) 116
administration, oral (114) 114
bone mineral density (113) 113
pharmacology & pharmacy (111) 111
drug administration schedule (109) 109
time factors (107) 107
research (106) 106
endocrinology (103) 103
rats (101) 101
prevention (99) 99
care and treatment (96) 96
medicine, general & internal (96) 96
density (92) 92
fractures, bone - prevention & control (92) 92
double-blind (90) 90
randomized-trial (89) 89
health aspects (88) 88
randomized controlled trials as topic (87) 87
zoledronic acid (87) 87
analysis (85) 85
calcium channel blockers - therapeutic use (85) 85
diphosphonates - adverse effects (81) 81
bone (80) 80
hip fracture (80) 80
osteoporosis - prevention & control (79) 79
diphosphonates - pharmacology (75) 75
alendronate - adverse effects (73) 73
osteoporosis, postmenopausal - complications (73) 73
spinal fractures - prevention & control (73) 73
dose-response relationship, drug (72) 72
diphosphonates (71) 71
follow-up studies (71) 71
mineral density (70) 70
dosage and administration (69) 69
medicine, research & experimental (69) 69
nonvertebral fractures (69) 69
risedronic acid (68) 68
bone and bones - drug effects (66) 66
osteoporosis, postmenopausal - prevention & control (63) 63
in-vitro (62) 62
internal medicine (62) 62
retrospective studies (61) 61
drug therapy, combination (60) 60
osteoporosis - complications (60) 60
alendronate - pharmacology (58) 58
bone remodeling - drug effects (58) 58
mice (58) 58
vertebral fracture (57) 57
efficacy (56) 56
imidazoles - therapeutic use (56) 56
prospective studies (56) 56
fracture (55) 55
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1078) 1078
German (48) 48
Japanese (32) 32
French (8) 8
Spanish (7) 7
Croatian (5) 5
Dutch (5) 5
Danish (3) 3
Turkish (3) 3
Hungarian (2) 2
Korean (2) 2
Lithuanian (2) 2
Portuguese (2) 2
Ukrainian (2) 2
Chinese (1) 1
Finnish (1) 1
Norwegian (1) 1
Polish (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, ISSN 0250-474X, 03/2019, Volume 81, Issue 2, pp. 309 - 316
The present investigation focussed on the development of a novel strategy to enhance the bioavailability of risedronate sodium, which has poor and erratic... 
32 full factorial design | DIAGNOSIS | DRUG-DELIVERY | RALOXIFENE | GUIDELINES | quasi-emulsion solvent diffusion | BISPHOSPHONATES | ORAL BIOAVAILABILITY ENHANCEMENT | in vitro buoyancy | in vitro drug release | FRACTURES | PHARMACOLOGY & PHARMACY | Risedronate sodium nanosponges
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 08/2017, Volume 12, pp. 5633 - 5642
Nanocrystalline hydroxyapatite containing selenite ions (SeHA; 9.6 wt.% of selenium) was synthesized using wet method and subject to careful physicochemical... 
Drug release | Composites | Ionic substitutions | Nanocrystalline hydroxyapatite | Antitumor activity | Cytotoxicity | Bisphosphonates | Biomaterials | CELLS | MECHANISM | DRUG-DELIVERY | NANOSCIENCE & NANOTECHNOLOGY | ADSORPTION | composites | NMR INVESTIGATIONS | NANOPARTICLES | ionic substitutions | antitumor activity | nanocrystalline hydroxyapatite | PHARMACOLOGY & PHARMACY | bisphosphonates | BIOMEDICAL APPLICATIONS | drug release | biomaterials | cytotoxicity | Osteosarcoma - drug therapy | Nanoparticles - chemistry | Humans | Drug Carriers - administration & dosage | Antineoplastic Agents - administration & dosage | Drug Carriers - chemistry | Anions | X-Ray Diffraction | Antineoplastic Agents - pharmacology | Spectroscopy, Fourier Transform Infrared - methods | Bone Neoplasms - drug therapy | Glucuronic Acid - chemistry | Microscopy, Electron, Transmission | Selenium - chemistry | Magnetic Resonance Spectroscopy | Durapatite - chemistry | Hexuronic Acids - chemistry | Powders - chemistry | Risedronic Acid - pharmacokinetics | Alginates - chemistry | Cell Line, Tumor | Porosity | Risedronic Acid - administration & dosage | Selenium - pharmacokinetics | Risedronic Acid - chemistry | Selenium - administration & dosage | Risedronate | Drugs | Drug delivery systems | Pharmacology, Experimental | Bone tumors | Research | Vehicles | Selenite | Nanocrystals | Dosage and administration | Chemical properties | Drug therapy | Health aspects | Fourier transforms | Nuclear magnetic resonance--NMR | Disease | Laboratories | Hydroxyapatite | Metastasis | Metabolism | Defects | Bone cancer | Biomedical materials | Sodium | Microscopy | Pharmacy | Skin & tissue grafts | Bones | Scientific imaging | Selenium | Tumors | risedronate
Journal Article
Journal Article
Journal of Comparative Pathology, ISSN 0021-9975, 01/2015, Volume 152, Issue 1, pp. 68 - 68
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 2011, Volume 79, Issue 3, pp. 601 - 611
Effect of varying NaCl concentration in either internal/external phase of the w/o/w emulsion on the morphology of risedronate sodium loaded PLGA microspheres.... 
Risedronate | Microspheres | Pulmonary | Surface engineer | Osmogen | PULMONARY DRUG-DELIVERY | LARGE-POROUS-PARTICLES | FREE NANOPOROUS MICROPARTICLES | FORMULATION | ALENDRONATE | BISPHOSPHONATES | IN-VITRO EVALUATION | ACID MICROSPHERES | SYSTEMS | PHARMACOLOGY & PHARMACY | SUSTAINED-RELEASE | Osmotic Pressure | Biocompatible Materials - chemistry | Humans | Male | Drug Carriers - chemistry | Bone and Bones - drug effects | Tissue Distribution | Etidronic Acid - pharmacokinetics | Bone and Bones - metabolism | Pulmonary Alveoli - metabolism | Surface Properties | Drug Compounding | Pulmonary Alveoli - drug effects | Lung - metabolism | Risedronate Sodium | Etidronic Acid - analogs & derivatives | Bone Density Conservation Agents - chemistry | Sodium Chloride - chemistry | Bone Density Conservation Agents - pharmacokinetics | Cell Line | Cell Survival - drug effects | Etidronic Acid - administration & dosage | Lung - pathology | Microscopy, Electron, Scanning | Lactic Acid - chemistry | Bone Density Conservation Agents - toxicity | Solubility | Administration, Inhalation | Rats | Bone Density Conservation Agents - administration & dosage | Particle Size | Animals | Lung - drug effects | Polyglycolic Acid - chemistry | Calorimetry, Differential Scanning | Delayed-Action Preparations | Etidronic Acid - chemistry | Etidronic Acid - toxicity
Journal Article
Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi, ISSN 1302-0234, 2017, Volume 63, Issue 2, pp. 165 - 173
Objectives: This study aims to investigate the effect of alendronate sodium on trabecular bone structure in an osteoporotic rat model. Materials and methods:... 
Biomechanics | Osteoporosis | Densitometry | Alendronate sodium | Histomorphometry | RESORPTION | ABSORPTIOMETRY | STRENGTH | biomechanics | osteoporosis | OVARIECTOMIZED RATS | MECHANICAL-PROPERTIES | MENATETRENONE | histomorphometry | POSTMENOPAUSAL OSTEOPOROSIS | CONNECTIVITY | densitometry | MASS | REHABILITATION | RISEDRONATE | Physiological aspects | Trabecular bone | Research | Alendronate | Health aspects
Journal Article
Acta Poloniae Pharmaceutica - Drug Research, ISSN 0001-6837, 2016, Volume 73, Issue 5, pp. 1267 - 1274
In this study, sustained release superabsorbent copolymer particles have been prepared and analyzed to increase bioavailability of orally administered... 
Superabsorbent polymer | Itaconic acid | Relative bioavailability | Chitosan | 2-hydroxyethyl methacrylate | Risedronate sodium | itaconic acid | chitosan | superabsorbent polymer | relative bioavailability | HYDROGELS | risedronate sodium | DRUG-DELIVERY | PHARMACOLOGY & PHARMACY | RELEASE
Journal Article
International Journal of Pharmacy and Technology, 09/2016, Volume 8, Issue 3, pp. 15510 - 15515
Journal Article